Detalhe da pesquisa
1.
Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
Ann Surg Oncol
; 26(12): 3807-3808, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471841
2.
Immune System Disorder and Cancer-Associated Cachexia.
Cancers (Basel)
; 16(9)2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730660
3.
The relationship between weight gain during chemotherapy and outcomes in patients with advanced non-small cell lung cancer.
J Cachexia Sarcopenia Muscle
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468440
4.
Mortality burden of pre-treatment weight loss in patients with non-small-cell lung cancer: A systematic literature review and meta-analysis.
J Cachexia Sarcopenia Muscle
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650388
5.
Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-small Cell Lung Cancer.
Cureus
; 14(9): e29423, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36299962
6.
Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy.
Cancers (Basel)
; 13(6)2021 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33804721
7.
Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis.
Curr Med Res Opin
; 36(9): 1497-1505, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615813
8.
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.
J Clin Oncol
; 37(4): 278-285, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550363
9.
Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors.
Clin Cancer Res
; 13(15 Pt 2): s4606-12, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17671150
10.
Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
Clin Cancer Res
; 13(15 Pt 2): s4583-8, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17671145
11.
Severe Exacerbation of Myasthenia Gravis Associated with Checkpoint Inhibitor Immunotherapy.
J Neuromuscul Dis
; 4(2): 169-173, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28505981
12.
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Lung Cancer
; 104: 126-130, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28212994
13.
Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC).
Radiother Oncol
; 81(2): 163-7, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17050016
14.
Clinician Perspectives on Current Issues in Lung Cancer Drug Development.
J Thorac Oncol
; 11(9): 1387-96, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401214
15.
Treatment of advanced squamous cell carcinoma of the lung: a review.
Transl Lung Cancer Res
; 4(5): 524-32, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26629421
16.
Novel treatments in non-small cell lung cancer.
Hematol Oncol Clin North Am
; 18(1): 245-67, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15005292
17.
Therapeutic advances in second-line treatment of advanced non-small-cell lung cancer.
Clin Lung Cancer
; 6(3): 154-61, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15555216
18.
Epidermal growth factor receptor-targeted therapy and symptom improvement in non-small cell lung cancer.
Am J Health Syst Pharm
; 60(24 Suppl 9): S16-21, 2003 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14717024
19.
Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional study.
J Appl Clin Med Phys
; 5(4): 15-28, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15738918
20.
Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer.
J Thorac Oncol
; 8(3): 338-45, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23370316